Lataa...
siRNA Therapeutics against Respiratory Viral Infections—What Have We Learned for Potential COVID‐19 Therapies?
Acute viral respiratory tract infections (AVRIs) are a major burden on human health and global economy and amongst the top five causes of death worldwide resulting in an estimated 3.9 million lives lost every year. In addition, new emerging respiratory viruses regularly cause outbreaks such as SARS‐...
Tallennettuna:
| Julkaisussa: | Adv Healthc Mater |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995229/ https://ncbi.nlm.nih.gov/pubmed/33506607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.202001650 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|